Alliance for Natural Health USA – Protecting Natural Health

Alliance for Natural Health USA - Protecting Natural Health | ANH Protects Free Speech About Natural · anh-usa.org · American English

The Alliance for Natural Health USA (ANH-USA) works to protect access to natural therapies and regenerative practices for ourselves and the planet.

rss2 audio content slash wfw atom dc sy

Open the feed

https://anh-usa.org/feed/

Last post: Sep 18, 2026
Posts in 24 h · 7 days · 30 days: 0 · 1 · 10
Our last check: Answering
Served from: United States
Site title: Alliance for Natural Health USA - Protecting Natural Health
Text score at discovery: 9,967
Format: rss2
Features in the feed: content, slash, wfw, atom, dc, sy

Posts

What our queue read from this feed. Open one to read it here, or go to the site that published it.

ANH-USA asks federal court to overturn FDA suppression of 114 government-backed nutrient health claims
Sep 18, 2026 · original
In its summary judgement motion ANH argues FDA has unlawfully converted a congressionally mandated notification pathway into a pre-approval system — preventing government-backed truthful nutrient–disease information from reaching the public ALEXANDRIA, VA, September 18, 2026 — The Alliance for Natural Health USA (ANH-USA), together with four dietary supplement companies, filed a motion for summary judgment asking the U.S. District Court for the District of Columbia to rule that the U.S. Food and Drug Administration (FDA) violated the First Amendment and the Food Drug and Cosmetic Act when it suppressed 114 nutrient-disease risk reduction claims based on statements published by federal government health agencies. The motion, filed September 16, 2026, is the latest step in litigation brought by ANH-USA, Living Fuel International, Health Ranger Store, Sanacor International and Evolution Nut
Stop Letting Drug Companies Push Supplements Off the Shelf
Sep 17, 2026 · original
A new bill could close the back channel that lets drug companies threaten your access to supplements—and Congress needs to hear your support now. Action Alert! Listen to the audio version of this article” THE TOPLINE Drug preclusion rules can block supplement sales because of earlier drug approvals or research, putting affordable options at risk. The battles over NMN, CBD, and NAC show why consumers need lasting protections. Urge your representative to support H.R. 10336, the Dietary Supplement Innovation Act, and your senators to advance companion legislation. A New Bill to Protect Your Supplements A new bill in Congress would help protect your access to supplements by making it harder for Big Pharma to create monopolies on natural ingredients—something we at ANH have called the FDA back-channel that allows drug companies to turn supplements into drugs. The Dietary Supplement Innovation
Is Human Health Rooted in the Soil?
Sep 17, 2026 · original
New research shows that the way food is grown may influence its nutritional value—and that healthy food begins with healthy soil. Action Alert! Listen to the audio version of this story: THE TOPLINE Growing practices and soil conditions can affect crop compounds such as polyphenols, vitamins, and pigments. Regenerative and organic practices—cover crops, crop rotations, lower disturbance—produce healthier soil, reduced pesticide/herbicide use, and more nutrient-dense foods that support the gut microbiome and other human health factors. Congress must support soil health measures in the Farm Bill, including the Agriculture Resilience Act, Soil CARE Act, and SCALE Act, with pesticide oversight and safeguards for contaminated amendments. You can fill your cart with vegetables, cook meals from scratch, and do everything you are told is healthy. But what if the food itself is not as nourishing
GRAS/NDI Double Trouble for Your Supplement Access
Sep 10, 2026 · original
A pending FDA guidance on new dietary ingredients underscores why the agency’s GRAS overhaul could determine which natural products reach market—and which are eliminated. Action Alert! Listen to the audio version of this article: THE TOPLINE FDA guidance addressing the identity and safety evidence required for new dietary ingredients is undergoing White House review. GRAS determinations and new dietary ingredient notifications are closely connected, underscoring why GRAS reform has such a major impact on the supplement industry. FDA must increase transparency without creating regulatory burdens, suppressing innovation, and reducing consumer access. The Food and Drug Administration (FDA) is scheduled to release another set of guidance documents that will control how innovative dietary ingredients reach the market. A guidance titled New Dietary Ingredient Notifications and Related Issues;
The GLP-1 Generation: Are We Medicating Childhood Obesity Instead of Preventing It?
Sep 10, 2026 · original
Prescriptions of GLP-1 drugs to children under 12 are rising at extraordinary speed. Are we turning a childhood health crisis into a lifetime pharmaceutical market? Listen to the audio version of this article: THE TOPLINE A national study found that 20,282 US children ages 8–11 with obesity but not diabetes received a GLP-1 prescription between 2019 and June 2026—a 310-fold increase. Wegovy’s safety and effectiveness for weight reduction have not been established in children under 12, and its adolescent evidence rests largely on one 68-week trial. New pancreatitis and vision warnings, together with surging FDA adverse-event reports, reinforce the need for stronger long-term surveillance. The GLP-1 boom is moving into the elementary-school years. A new Pediatrics study examined more than 3.5 million children ages 8–11 with obesity but not diabetes. Researchers found that 20,282 received p
Who Decides What Counts as Medicine? Rob Verkerk Explains How to Fix the Food-Drug Divide
Sep 10, 2026 · original
ANH founder Rob Verkerk explains why outdated food-drug definitions restrict consumer access to natural health options—and how a more proportionate system could better protect both choice and safety. Listen to the audio version of this article: The following is a transcript of an interview with Rob Verkerk, PhD, and ANH-USA’s Editorial Director, Michael Ames-Sikora. Today I’m speaking with ANH founder and executive director Rob Verkerk about Beyond Binary Food-Drug Definitions: A Case for US and EU Modernization . Accepted for publication in the Journal of Food Law & Policy on July 20, 2026, and expected to appear in spring 2027, the paper was written by Rob as lead author and principal investigator, ANH legal researcher Chimnonso Onyekwelu, and our general counsel, Jonathan W. Emord—the “FDA Dragon Slayer,” who holds the record for the most legal victories against the agency. At its hea
FDA Misses Deadline as Sweeping Federal Cannabinoid Ban Approaches
Sep 3, 2026 · original
The federal government is preparing to outlaw many full-spectrum hemp products while withholding basic information businesses need to understand the new law. If you care about your access to CBD and other non-intoxicating cannabinoids, please sign our Action Alert now! Listen to the audio version of this article: THE TOPLINE FDA missed its February 10 deadline to clarify which cannabinoids count toward the new 0.4-milligram-per-container limit and what constitutes a “container,” leaving hemp businesses unable to prepare for the December 2026 restrictions. The new definition threatens many non-intoxicating, full-spectrum CBD products—not just synthetic intoxicants. Congress should enact the Hemp Planting Predictability Act to delay implementation and the Cannabinoid Safety and Regulation Act to establish risk-based safety standards while preserving access to responsibly made hemp products
HHS Takes Aim at the Medical-Industrial Complex
Sep 3, 2026 · original
A new HHS report on questionable medical billing is part of a broader—yet at times inconsistent—effort to challenge pharmaceutical influence, improve nutrition, lower healthcare costs, and shift federal policy toward prevention. Listen to the audio version of this article: THE TOPLINE A new HHS report alleges that hospitals used questionable diagnostic codes to obtain insurance reimbursement for expensive medical interventions, exposing how financial incentives can distort patient care. Over the last two years, HHS has also advanced food-dye reform, infant-formula testing, nutrition education, drug-price negotiations, price transparency, and prior-authorization reform. These actions represent meaningful progress, but HHS must apply its skepticism consistently—including when FDA policies threaten individualized, natural, and non-patentable treatments. A new report commissioned by the Depa
My Adverse Drug Reaction—and the Healthcare Lesson We Can’t Ignore
Aug 28, 2026 · original
By Rob Verkerk, PhD, ANH founder and ANH-USA executive and scientific director This article is adapted from a longer personal account first published by ANH International. Listen to the audio version of this article: THE TOPLINE I developed a suspected serious hypersensitivity reaction within days of starting allopurinol ahead of foot surgery. My experience raises difficult questions about informed consent, individualized risk, baseline testing, dosing and monitoring. We do not need a war between conventional and natural medicine. We need connected healthcare that puts the person before the protocol. For most of my adult life, I have lived almost entirely outside the pharmaceutical model—not because of ideology, but because of experience. In my twenties, I was diagnosed with multiple chemical sensitivity following severe reactions to pesticides, solvents and pharmaceutical drugs. A parti
Is Your Pet Being Exploited to Aid Pharma Profits?
Aug 28, 2026 · original
As animal health shifts toward pharma and biotech-driven interventions, basic determinants like nutrition, exercise and stress are being sidelined despite their immense impact on both health-span and lifespan. Original article by Melissa Smith, Outreach & Communications Officer, ANH International Abbreviated version below edited by Mike Ames-Sikora, Senior Editor, ANH-USA. Read the full version at ANH International Listen to the audio version of this article: THE TOPLINE Animals are increasingly developing the same chronic diseases as humans, driven by factors such as ultra-processed diets, inactivity, toxin exposure, stress and intensive farming conditions. Animal health is becoming more pharmaceuticalized, with growing use of drugs, novel vaccine technologies and biotech platforms, while questions remain around long-term safety, transparency and food-chain exposure. We need a preventio

Discovered by the rss-feed-index crawler, which checks each feed at most once a month.

Same record as JSON: https://api.agentalog.com/api/feeds/fd_anh_usa_org_343d7217368c1a3f. More from this site: anh-usa.org in the Feeds tab.